Latvia - Nervous System Medicine Use
Since 2014, Latvia Nervous System Medicine Use rose 4.5% year on year. With 105.5 Units (Defined Daily Dosage) Per Thousand Persons Per Day in 2019, the country was ranked number 26 comparing other countries in Nervous System Medicine Use. Latvia is overtaken by South Korea, which was number 25 with 106.8 Units (Defined Daily Dosage) Per Thousand Persons Per Day and is followed by Turkey with 103.3 Units (Defined Daily Dosage) Per Thousand Persons Per Day. Portugal topped the ranking with 344.9 Units (Defined Daily Dosage) Per Thousand Persons Per Day in 2019, that is +5.5% compared to 2018. Iceland, Sweden and Spain respectively ranked number 2, 3 and 4 in this ranking. Canada recorded the best 5 years average growth at +7.2% per year, while Slovakia was the worst growing country at -2.9% per year.
Loading...
| Date | Units (Defined Daily Dosage) Per Thousand Persons Per Day |
|---|---|
| 2019 | 105.50 |
| 2018 | 98.60 |
| 2017 | 97.50 |
| 2016 | 92.10 |
| 2015 | 88.80 |
How does Latvia rank in Nervous System Medicine Use?
| # | 28 Countries | Units (Defined Daily Dosage) Per Thousand Persons Per Day | Last | YoY | 5‑years CAGR | ||
|---|---|---|---|---|---|---|---|
| 1 |
#1
Portugal
|
345 | 2019 | +5.5 % | +2.4 % | View data | |
| 2 |
#2
Iceland
|
343 | 2019 | +2.1 % | +2.5 % | View data | |
| 25 |
#25
South Korea
|
107 | 2019 | +1.0 % | +1.1 % | View data | |
| 26 |
#26
Latvia
|
106 | 2019 | +7.0 % | +4.5 % | View data | |
| 27 |
#27
Turkey
|
103 | 2019 | +2.2 % | +3.6 % | View data | |